Oncolys BioPharma News

Oncolys BioPharma: Change Report

Oct 22 21:42 ET

Oncolys BioPharma: Change Report (short-term mass transfer)

Oct 22 02:28 ET

Oncolys BioPharma: Change Report

Oct 20 21:19 ET

Oncolys BioPharma: Change report.

Oct 18 02:21 ET

Oncolys BioPharma: Change Report

Sep 19 22:19 ET

Oncolys BioPharma: Change Report

Aug 20 23:51 ET

Oncolys BioPharma: Change Report

Aug 13 21:52 ET

Oncolys BioPharma: Change Report

Jul 31 21:59 ET

Oncolys BioPharma: Mass Ownership Report

Jul 7 22:16 ET

Oncolys BioPharma: Announcements of the issuance of the 20th subscription rights (with exercise price adjustment clause and exercise suspension clause) through third-party allocation have been completed for payment.

Jul 1 02:00 ET

Oncolys BioPharma: Announcements of individual stocks regarding the issuance of the 20th subscription rights by third-party allocation (with modification clause for exercise price and suspension clause for exercise) and the conclusion of the purchase agreement (commitment issue) of subscription rights.

Jun 14 03:00 ET

Oncolys BioPharma: Supplementary explanatory materials regarding the issuance of the 20th subscription rights through third-party allocation.

Jun 14 03:00 ET

Oncolys BioPharma: Securities registration statement (referencing method).

Jun 14 02:00 ET

Oncolys BioPharma: Notice Concerning Issuance of New Shares as Stock Compensation with Transfer Restricted Shares

Mar 15 03:00 ET

Oncolis Biopharma: Change Report (Stock Certificates Subject to Special Cases, etc.)

Feb 21 23:53 ET

Oncolys BioPharma: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Jan 10 22:40 ET

Oncolys BioPharma: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Nov 22, 2023 00:06 ET

Oncolys BioPharma: Change Report

Nov 7, 2023 23:47 ET

Oncolys BioPharma: Change Report

Oct 31, 2023 00:05 ET

Oncolys BioPharma: Change Report

Oct 22, 2023 23:03 ET